Ευρωπαϊκή Ένωση -
Ελληνικά -
EMA (European Medicines Agency)
thiotepa riemser
esteve pharmaceuticals gmbh - θειοτέπα - hematopoietic stem cell transplantation; neoplasms - Αντινεοπλασματικοί παράγοντες - thiotepa riemser is indicated, in combination with other chemotherapy medicinal products:with or without total body irradiation (tbi), as conditioning treatment prior to allogeneic or autologous haematopoietic progenitor cell transplantation (hpct) in haematological diseases in adult and paediatric patients;when high dose chemotherapy with hpct support is appropriate for the treatment of solid tumours in adult and paediatric patients. thiotepa riemser is indicated, in combination with other chemotherapy medicinal products:with or without total body irradiation (tbi), as conditioning treatment prior to allogeneic or autologous haematopoietic progenitor cell transplantation (hpct) in haematological diseases in adult and paediatric patients;when high dose chemotherapy with hpct support is appropriate for the treatment of solid tumours in adult and paediatric patients.
Ελλάδα -
Ελληνικά -
Εθνικός Οργανισμός Φαρμάκων
osanit 100 iu/dose(σταθ.δοσ naspr.sol
iasis pharmac.hellas ΒΙΟΜ.& ΕΜΠ.Φ/ΚΩΝ-ΧΗΜ/ΚΩΝ & ΚΑΛ.ΠΡ.ΑΒΕΕ - calcitonin (salmon synthetic) - ΡΙΝΙΚΟ ΕΚΝΕΦΩΜΑ, ΔΙΑΛΥΜΑ - 100 iu/dose(σταθ.δοσ - ΦΑΡΜΑΚΕΥΤΙΚΟ ΠΡΟΪΟΝ
Ελλάδα -
Ελληνικά -
Εθνικός Οργανισμός Φαρμάκων
osanit 200 iu/dose naspr.sol
iasis pharmac.hellas ΒΙΟΜ.& ΕΜΠ.Φ/ΚΩΝ-ΧΗΜ/ΚΩΝ & ΚΑΛ.ΠΡ.ΑΒΕΕ - calcitonin (salmon synthetic) - ΡΙΝΙΚΟ ΕΚΝΕΦΩΜΑ, ΔΙΑΛΥΜΑ - 200 iu/dose - ΦΑΡΜΑΚΕΥΤΙΚΟ ΠΡΟΪΟΝ